Who we work with

Built for teams at every stage.

From early-stage startups validating their first SaMD concept, to established manufacturers expanding into new markets, to investors evaluating a MedTech portfolio, we tailor our approach to where you are right now.

Three audiences, three approaches.

Each audience has different pressures, timelines and budgets. Here’s how we engage with each.

Accelerate to Market

Startups & Scaleups

You have a breakthrough SaMD or medical device but you’re not sure what’s required to get it to market. Time and runway are tight, and a wrong regulatory choice early can cost months.

What we typically help with

  • Early-stage regulatory feasibility & classification
  • Lean ISO 13485 QMS that grows with you
  • Investor / due-diligence regulatory pack
  • SaMD-specific IEC 62304 setup from day one
  • Startup Office Hours, quick ad-hoc calls
  • Market sequencing: where to launch first

Expand & Stay Compliant

Medical Device Companies

You want to expand into new markets or meet evolving requirements like MDR, QMSR or ISO 13485. We work with your team to navigate technical files, compliance gaps, and regulatory submissions across regions, as a consultant, trainer, or an extra pair of hands.

What we typically help with

  • Multi-market submission strategy (FDA, EU, UK, AU, NZ)
  • Technical documentation gap analysis
  • MDR / QMSR transition support
  • External PRRC and QMR roles
  • Internal audits & training (RBP certified)
  • In-country representation (UK, AU, NZ)

De-Risk Investments

Investors & Portfolios

You need to understand if a MedTech investment is regulatory-ready, or how far off it is. We provide due diligence, compliance assessments and strategic clarity for your portfolio companies, without slowing the deal.

What we typically help with

  • Regulatory due diligence pre-investment
  • Portfolio company compliance assessment
  • Realistic time-to-market estimates
  • Red flags & critical-path identification
  • Post-investment regulatory support plans
  • Board-level regulatory briefings

Not sure which fits you?

Tell us about your product or portfolio in a 30-minute call. We’ll tell you honestly where you stand and what the next sensible step is.